Fibroblast Growth Factor 19 and Fibroblast Growth Factor 21 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Gastric Bypass
Open Access
Abstract
Background: Gastric bypass (GB) is an effective treatment for those who are morbidly obese with coexisting type 2 diabetes mellitus (T2DM) or non-alcoholic fatty liver disease (NAFLD). Fibroblast growth factors (FGFs) are involved in the regulation of energy metabolism. Methods: We investigated the roles of FGF 19, FGF 21, and total bile acid among those with morbidly obese and T2DM undergoing GB. A total of 35 patients were enrolled. Plasma FGF 19, FGF 21, and total bile acid levels were measured before surgery (M0), 3 months (M3), and 12 months (M12) after surgery, while the hepatic steatosis index (HSI) was calculated before and after surgery. Results: Obese patients with T2DM after GB presented with increased serum FGF 19 levels (p = 0.024) and decreased total bile acid (p = 0.01) and FGF 21 levels (p = 0.005). DM complete remitters had a higher FGF 19 level at M3 (p = 0.004) compared with DM non-complete remitters. Fatty liver improvers tended to have lower FGF 21 (p = 0.05) compared with non-improvers at M12. Conclusion: Changes in FGF 19 and FGF 21 play differential roles in DM remission and NAFLD improvement for patients after GB. Early increases in serum FGF 19 levels may predict complete remission of T2DM, while a decline in serum FGF 21 levels may reflect the improvement of NAFLD after GB.Keywords
Funding Information
- Ministry of Science and Technology, Israel (MOST 104-2314-B-010-005)
- Taipei Veterans General Hospital (V99F-010, V101C-118)
- Cheng Hsin General Hospital, and the National Yang-Ming University Joint Research Program (103F003C13)
This publication has 64 references indexed in Scilit:
- Fundamentals of FGF19 & FGF21 Action In Vitro and In VivoPLOS ONE, 2012
- Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomySurgery for Obesity and Related Diseases, 2011
- Obesity, diabetes mellitus, and liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult MouseMolecular Endocrinology, 2010
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant StateDiabetes, 2010
- Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21Diabetes, 2009
- Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21Cell Metabolism, 2008
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Cell Metabolism, 2007
- Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in manJournal of Internal Medicine, 2006
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasisCell Metabolism, 2005